¹û¶³´«Ã½

Michael A. Rees, M.D., Ph.D.

Medical Education and Training:

• M.D. University of Michigan, Ann Arbor
• Ph.D. University of Cambridge, Cambridge U.K.
• Resident in Urology, University of Virginia, Charlottesville
• Fellow in Transplantation, University of Cambridge, Cambridge U.K.

Board Certification:

• American Board of Urology

Clinical Interests:

• Renal transplantation
• Kidney paired donation
• Tissue typing
• Urological oncology

Research Interests:

• Kidney paired donation
• Xenotransplantation
• Extracorporeal perfusion of porcine liver

Representative Recent Publications:

• Tedesco-Silva H, Pescovitz MD, Cibrik D, Rees MA, Mulgaonkar S, Kahan BD, Gugliuzza KK, Rajagopalan PR, Esmeraldo Rde M, Lord H, Salvadori M, Slade JM, and the FTY720 Study Group:Ìý Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation.Ìý Transplantation 82:1689-97, 2006
• Burlak C, Twining LM, Rees MA:Ìý Terminal sialic acid residues on human glycophorin A are recognized by porcine kupffer cells.Ìý Transplantation.80:344-52, 2005
• Burlak C, Twining LM, Rees MA:Ìý Carbohydrates borne on human glycophorin A are recognized by porcine Kupffer cells.Ìý Transplantation 80:66-74, 2005
• Rees MA, Butler AJ, Brons IG, Negus MC, Skepper JN, Friend PJ:Ìý Evidence of macrophage receptors capable of direct recognition of xenogeneic epitopes without opsonization. Xenotransplantation 12:13-9, 2005
• Rees MA:Ìý A novel role for lectins in xenotransplantation. Xenotransplantation 12:7-12, 2005

---

Dr. Rees discloses the following conflicts of interest:

• Rejuvenate Healthcare where he receives equity, consulting fees, travel reimbursement and serves on the board of directors. In addition, his wife receives equity and consulting fees from Rejuvenate Healthcare.
• Alliance for Paired Kidney Donation, a 501c3 not-for-profit organization, where Dr. Rees receives consulting fees, travel reimbursement and serves on the board of directors and his wife receives a salary.
• Life Connection of Ohio where Dr. Rees serves as the unpaid Chairman of the Board of Directors.
• For the relationships/affiliations above, the following are true:
  • These relationships/affiliations will not bias or otherwise influence Dr. Rees' involvement in any CME activity.
  • Practice recommendations given relevant to the companies with whom I have relationships/affiliations will be supported by best available evidence or, absent evidence, will be consistent with generally accepted medical and scientific practice.
  • All reasonable clinical alternatives will be discussed when making practice recommendations.